Pricing Log in Create free account

Moolec Science SA (MLEC) vs Vincerx Pharma, Inc. (VINC)

Moolec Science SA and Vincerx Pharma, Inc. are both Biotechnology companies. Moolec Science SA is the larger, with a market value of $620.0K against $250.0K — 2.5× the size. Vincerx Pharma, Inc. has the higher net margin (0.00% vs −105.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Moolec Science SA leads on 8 and Vincerx Pharma, Inc. on 5.

Valuation

Metric MLEC VINC Biotechnology median
P/E n/m n/m 10.60
P/S 0.03 n/m 9.40
P/B 0.01 0.03 2.13
Price to free cash flow 0.01 n/m 25.18
EV/EBITDA 1.76 0.17 0.66
EV/Sales 8.37 n/m 9.02
Earnings yield (3,822.12%) (46,330.00%) (32.88%)
Free cash flow yield 8,301.70% (32,262.57%) (23.13%)

Profitability

Metric MLEC VINC Biotechnology median
Gross margin 2,373.25% 0.00% 68.51%
Operating margin 244.93% 0.00% 0.00%
Net margin (105.71%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (3,136.43%) (51.96%)
Return on assets 0.00% (287.21%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MLEC VINC Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (793.17%) 58.07% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MLEC VINC Biotechnology median
Debt to equity 4.37 0.00 0.00
Current ratio 0.15 1.79 4.97
Net debt to EBITDA (2.73) 0.17 1.01

Dividend

Metric MLEC VINC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MLEC VINC Biotechnology median
Market cap 620.00k 250.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack